Warren Buffett's final shareholder letter marks a historic transition in the investment world. This creates a unique opportunity to position yourself in companies that carry forward his legendary approach.
These companies embody the timeless qualities Buffett championed: strong fundamentals, durable competitive advantages, and patient capital appreciation. Quality never goes out of style.
As investors search for the next 'Berkshire-like' opportunities, capital may flow toward these proven value-focused businesses, potentially supporting their long-term growth.
This basket's total market capitalisation is 359,045.7447000001 and is heavily anchored by a few very large-cap holdings, creating a stable, large-cap profile.
MKL: $24.90B
WRB: $27.10B
BN: $113.98B
Warren Buffett's final shareholder letter signals the end of a defining era in finance. As the Oracle of Omaha prepares to pass the torch, this creates a unique opportunity to invest in companies that embody his legendary value-investing principles. We've identified businesses with strong fundamentals, durable competitive advantages, and a commitment to long-term capital appreciation.
This group focuses on quality-driven, long-term investments that mirror Buffett's approach. It includes diversified holding companies, disciplined asset managers, and value-focused funds. These are businesses built for patience and steady growth rather than quick gains, making them suitable for investors who appreciate the Berkshire Hathaway philosophy of buying and holding great companies.
Each stock was handpicked by professional analysts for exhibiting 'Buffett-esque' qualities. From Berkshire Hathaway itself to companies often called 'mini-Berkshires,' these selections represent the best examples of value investing in practice. As capital may flow toward firms with proven long-term value creation, this curated list positions investors in the post-Buffett landscape.
Warren Buffett's final letter to shareholders marks a major transition for Berkshire Hathaway and the investment world. This creates an opportunity to invest in companies that embody his legendary value-investing philosophy.
Published on November 1
+3
Here are a few of the assets in this group. Create an account to unlock the full list.
MARKEL GROUP INC
MKL
Current Price
$1,842.54
Often referred to as a 'mini-Berkshire,' Markel combines a specialty insurance business with a diversified portfolio of investments, mirroring Buffett...
Often referred to as a 'mini-Berkshire,' Markel combines a specialty insurance business with a diversified portfolio of investments, mirroring Buffett's model.
BERKLEY(W.R.)CORP
WRB
Current Price
$71.42
This insurance holding company operates in a sector that is a cornerstone of Berkshire Hathaway's portfolio, reflecting a focus on long-term value and...
This insurance holding company operates in a sector that is a cornerstone of Berkshire Hathaway's portfolio, reflecting a focus on long-term value and risk management.
BROOKFIELD CORPORATION
BN
Current Price
$38.46
Brookfield is a global asset manager with a long-term investment horizon, similar to Berkshire Hathaway's approach to acquiring and holding businesses...
Brookfield is a global asset manager with a long-term investment horizon, similar to Berkshire Hathaway's approach to acquiring and holding businesses.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
On average, analysts expect assets in this group to grow 7.54% over the next year.
8 of 13 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+7.54%
Get the full story on this Basket. Read our detailed article on its risks and potential.
Read Full Insight
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
